You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 112 No. 9, September 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

T-Lymphocytes as a Prognostic Indicator in Head and Neck Cancer

David E. Schuller, MD; Raymond P. Rock, MD; John J. Rinehart, MD; Antoinette R. Koolemans-Beynen, MS

Arch Otolaryngol Head Neck Surg. 1986;112(9):938-941.


Abstract

• The relationship of a cancer patient's immunoreactivity and prognosis appears to be more complex than originally reported. Many earlier studies seemed to show that these assessments of immune competence had prognostic significance. Later reports showed no correlation. Newer technology has given the capability of measuring T-lymphocyte subpopulations and offers the possibility of a more sophisticated assessment of immunoreactivity that might correlate with prognosis. A study of 59 head and neck cancer patients was undertaken to assess the value of measuring the T-cell subpopulations in the peripheral blood and from regional neck lymph nodes. This study shows no difference between those patients free of disease and those either living or dying of disease. The conclusion of this study is that the measurement of T-cell subpopulations offers no prognostic value for patients with head and neck carcinoma.

(Arch Otolaryngol Head Neck Surg 1986;112:938-941)



Author Affiliations

From the Comprehensive Cancer Center, The Ohio State University, Columbus.


Footnotes

Accepted for publication Feb 20, 1986.

Presented in part at the joint meeting of the American Society for Head and Neck Surgery and the Society of Head and Neck Surgeons, Dorado Beach, Puerto Rico, May 7, 1985.

Reprint requests to Department of Otolaryngology, The Ohio State University, 456 Clinic Dr, Columbus, OH 43210.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Alterations in T-Lymphocyte Subpopulations in Patients With Head and Neck Cancer: Correlations With Prognosis
Wolf et al.
Arch Otolaryngol Head Neck Surg 1987;113:1200-1206.
ABSTRACT  

T-Cell Subsets and Natural Killer Cell Function With Squamous Cell Carcinoma of the Head and Neck
Strome et al.
Arch Otolaryngol Head Neck Surg 1987;113:1090-1093.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.